fingolimod hydrochloride has been researched along with albuterol in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (albuterol) | Trials (albuterol) | Recent Studies (post-2010) (albuterol) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 10,108 | 3,059 | 2,058 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | albuterol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 1.2618 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fozard, JR; Trifilieff, A | 1 |
1 other study(ies) available for fingolimod hydrochloride and albuterol
Article | Year |
---|---|
Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor.
Topics: Albuterol; Animals; Asthma; beta-Alanine; Bronchial Hyperreactivity; Bronchoconstriction; Fingolimod Hydrochloride; Lung; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Propylene Glycols; Rats; Rats, Inbred BN; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Tachyphylaxis; Thiophenes; Trachea | 2012 |